The present study aims to: (1) determine whether MEFs can be directly reprogrammed into iNSCs using a combination of Sox2 and the chemical A-83-01, and (2) evaluate whether these iNSCs can be expanded in vitro to improve cognitive performance in AD mouse models. The gene discussed is SOX2; the disease is Alzheimer disease.